Aeroflex Incorporated Announces Acquisition of Racal Wireless Solutions Group.Business Editors/High-Tech Writers PLAINVIEW, N.Y.--(BUSINESS WIRE)--July 31, 2003 Aeroflex Incorporated (Nasdaq Symbol: ARXX), a leading designer, developer and manufacturer of automated testing (testing) automated testing - Software testing assisted with software tools that require no operator input, analysis, or evaluation. solutions and microelectronics for the aerospace, defense and broadband communications markets, announced today that it has acquired the Racal Wireless Solutions Group for cash of $38 million and a deferred payment of up to $16.5 million in either cash or Aeroflex common stock, at Aeroflex's option, depending on the Wireless Solutions Group achieving certain performance goals for the year ending July 31, 2004. Racal Wireless is a leading developer, manufacturer and integrator (1) In electronics, a device that combines an input with a variable, such as time, and provides an analog output; for example, a watt-hour meter. (2) See systems integrator. of digital wireless testing and measurement solutions. Its products address two primary wireless applications - infrastructure testing and mobile handset The part of the telephone that contains the speaker and the microphone. On a desktop phone, the part you hold in your hand is the handset. On a cellphone, the entire phone is the handset. See multihandset cordless and headset. testing. The Wireless Solutions Group's broad suite of test systems support all product life-cycle stages, including research and development, conformance con·for·mance n. Conformity. Noun 1. conformance - correspondence in form or appearance conformity agreement, correspondence - compatibility of observations; "there was no agreement between theory and , production, installation and commissioning, field service and network optimization optimization Field of applied mathematics whose principles and methods are used to solve quantitative problems in disciplines including physics, biology, engineering, and economics. , as well as nearly all 2G, 2.5G and 3G wireless standards. "The addition of Racal Wireless testing solutions products and technologies to our current product offerings will enable Aeroflex to provide a full spectrum of wireless testing solutions, from development to production and service," said Michael Gorin, President. "The Racal Instruments name is recognized worldwide as a leading edge provider of wireless testing solutions which has garnered them a top tier customer base. We expect that the proximity of the Racal Wireless U.K. facility to our existing U.K. operations will provide the two operations with the opportunity to share their respective expertise and achieve certain synergies. "For calendar 2002, Racal Wireless had sales of approximately $50 million with profitable operations. For the period of our ownership in our fiscal year ended June 30, 2004, we anticipate that Racal Wireless will contribute over $40 million in sales and be accretive to our earnings in the second half of our fiscal year." A conference call will be held on Monday, August 4, 2003 at 9:00 a.m. (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ) to discuss the Racal Wireless transaction. The dial-in number for calls made in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. is 888-396-2369 and outside the United States is 617-847-8710, Participant Code: 72103085. There will also be a replay of the call starting at approximately 11:00 a.m. (EDT) on Monday, August 4, 2003 and ending at 11:59 p.m. (EDT) on Monday, August 11, 2003. The telephone number for the replay is 888-286-8010 in the United States and 617-801-6888 outside of the United States, Passcode: 84559343 for both. This call is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at Aeroflex's website at www.aeroflex.com. This webcast will be archived on that site for one year. About Aeroflex Aeroflex Incorporated is a global provider of high technology solutions to the aerospace, defense and broadband communications markets. The Company's diverse technologies allow it to design, develop, manufacture and market a broad range of test, measurement and microelectronic products. The Company's common stock trades on the Nasdaq National Market System under the symbol ARXX and is included in the S&P SmallCap 600 index. Additional information concerning Aeroflex Incorporated can be found on the Company's website: www.aeroflex.com. All statements other than statements of historical fact included in this press release regarding Aeroflex's financial position, business outlook, business strategy and plans and objectives of its management for future operations are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . When used in this press release, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Aeroflex or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Aeroflex's management, as well as assumptions made by and information currently available to its management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, competitive factors and pricing pressures, the integration of the business of each of MCE See Media Center Edition. Technologies and of the Racal Wireless Solutions Group with Aeroflex, changes in legal and regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. , technological change or difficulties, product development risks, commercialization difficulties and general economic conditions. Such statements reflect our current views with respect to the future and are subject to these and other risks, uncertainties and assumptions relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc Aeroflex's financial condition, results of operations, growth strategy and liquidity. Aeroflex does not undertake any obligation to update such forward-looking statements. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion